{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:52:52Z","timestamp":1789084372552,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["BSC 0114"],"award-info":[{"award-number":["BSC 0114"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00018","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T04:30:38Z","timestamp":1517286638000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Liposomal Elongation Factor-1\u03b1 Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis"],"prefix":"10.3389","volume":"9","author":[{"given":"Abdus","family":"Sabur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra","family":"Chhajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfaraz Ahmad","family":"Ejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Didwania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utsa","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","article-title":"Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective","volume":"5","author":"Singh","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"B3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0185438","DOI":"10.1371\/journal.pone.0185438","article-title":"Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.vetpar.2013.05.008","article-title":"Vaccination with LiESP\/QA-21 (CaniLeish(R)) reduces the intensity of infection in Phlebotomus perniciosus fed on Leishmania infantum infected dogs \u2013 a preliminary xenodiagnosis study","volume":"197","author":"Bongiorno","year":"2013","journal-title":"Vet Parasitol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fimmu.2012.00069","article-title":"Vaccines for canine leishmaniasis","volume":"3","author":"Palatnik-de-Sousa","year":"2012","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.vetpar.2015.01.003","article-title":"Canine Leishmania vaccines: still a long way to go","volume":"208","author":"Gradoni","year":"2015","journal-title":"Vet Parasitol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2914","DOI":"10.1371\/journal.pntd.0002914","article-title":"Immune regulation during chronic visceral leishmaniasis","volume":"8","author":"Faleiro","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4269\/ajtmh.2006.74.1013","article-title":"Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase","volume":"74","author":"Murray","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"B15","doi-asserted-by":"publisher","first-page":"27206","DOI":"10.1038\/srep27206","article-title":"A lipid based antigen delivery system efficiently facilitates MHC class-I antigen presentation in dendritic cells to stimulate CD8(+) T cells","volume":"6","author":"Maji","year":"2016","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1586\/14760584.2014.894467","article-title":"Identifying vaccine targets for anti-leishmanial vaccine development","volume":"13","author":"Sundar","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fimmu.2017.00227","article-title":"Leishmania donovani nucleoside hydrolase (NH36) domains induce T-cell cytokine responses in human visceral leishmaniasis","volume":"8","author":"Barbosa Santos","year":"2017","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1128\/IAI.71.5.2924-2926.2003","article-title":"Th1\u2009cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis","volume":"71","author":"Pascalis","year":"2003","journal-title":"Infect Immun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.1016\/j.vaccine.2007.10.028","article-title":"Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB\/c mice","volume":"25","author":"Mazumder","year":"2007","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response","volume":"25","author":"Bhowmick","year":"2007","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"50190","DOI":"10.1074\/jbc.M209210200","article-title":"Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation","volume":"277","author":"Nandan","year":"2002","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0006-291X(03)00216-X","article-title":"Molecular cloning, biochemical and structural analysis of elongation factor-1 alpha from Leishmania donovani: comparison with the mammalian homologue","volume":"302","author":"Nandan","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B23","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/IAI.65.6.2371-2377.1997","article-title":"Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes","volume":"65","author":"Afrin","year":"1997","journal-title":"Infect Immun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice","volume":"70","author":"Afrin","year":"2002","journal-title":"Infect Immun"},{"key":"B25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.2448875","article-title":"Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase","volume":"239","author":"Saiki","year":"1988","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","article-title":"IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India","volume":"179","author":"Saha","year":"2007","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e3091","DOI":"10.1371\/journal.pntd.0003091","article-title":"Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection","volume":"8","author":"Das","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e5820","DOI":"10.1371\/journal.pone.0005820","article-title":"Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis","volume":"4","author":"Bhowmick","year":"2009","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/IAI.00611-07","article-title":"gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB\/c mice infected with Leishmania donovani","volume":"76","author":"Bhowmick","year":"2008","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1128\/IAI.01739-07","article-title":"Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection","volume":"77","author":"Bhowmick","year":"2009","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"202ra121","DOI":"10.1126\/scitranslmed.3006406","article-title":"Vaccination with Leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis","volume":"5","author":"Guha","year":"2013","journal-title":"Sci Transl Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fimmu.2013.00375","article-title":"Sand-fly saliva-Leishmania-man: the trigger trio","volume":"4","author":"Oliveira","year":"2013","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1000441","DOI":"10.1371\/journal.ppat.1000441","article-title":"Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania","volume":"5","author":"Collin","year":"2009","journal-title":"PLoS Pathog"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0149894","DOI":"10.1371\/journal.pone.0149894","article-title":"Identification of immunoreactive Leishmania infantum protein antigens to asymptomatic dog sera through combined immunoproteomics and bioinformatics analysis","volume":"11","author":"Agallou","year":"2016","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.meegid.2014.07.028","article-title":"What\u2019s behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity","volume":"28","author":"Abdeladhim","year":"2014","journal-title":"Infect Genet Evol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1089\/vbz.2014.1712","article-title":"Immunoproteomic identification of p29 antigen as the elongation factor-1alpha of Leishmania mexicana","volume":"15","author":"Piedra-Quintero","year":"2015","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1128\/CDLI.12.2.310-320.2005","article-title":"Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients","volume":"12","author":"Kamoun-Essghaier","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","article-title":"A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH","volume":"11","author":"Osman","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fmicb.2016.00312","article-title":"Comparative analysis of cellular immune responses in treated Leishmania patients and hamsters against recombinant Th1 stimulatory proteins of Leishmania donovani","volume":"7","author":"Joshi","year":"2016","journal-title":"Front Microbiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3389\/fimmu.2017.00750","article-title":"F1 domain of the Leishmania (Leishmania) donovani nucleoside hydrolase promotes a Th1 response in Leishmania (Leishmania) infantum cured patients and in asymptomatic individuals living in an endemic area of leishmaniasis","volume":"8","author":"Carrillo","year":"2017","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fimmu.2014.00241","article-title":"Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis \u2013 discovery and implications","volume":"5","author":"Gannavaram","year":"2014","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"343961","DOI":"10.4061\/2011\/343961","article-title":"Evasion of host defence by Leishmania donovani: subversion of signaling pathways","volume":"2011","author":"Shadab","year":"2011","journal-title":"Mol Biol Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1084\/jem.187.8.1193","article-title":"T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching","volume":"187","author":"Toellner","year":"1998","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CDLI.7.2.233-240.2000","article-title":"Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis","volume":"7","author":"Mukhopadhyay","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit Vectors"},{"key":"B50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13071-016-1777-x","article-title":"Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery","volume":"9","author":"Mendonca","year":"2016","journal-title":"Parasit Vectors"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1108","article-title":"Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites","volume":"10","author":"Zaph","year":"2004","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1016\/j.vaccine.2010.05.077","article-title":"Repeated inoculation of killed Leishmania major induces durable immune response that protects mice against virulent challenge","volume":"28","author":"Okwor","year":"2010","journal-title":"Vaccine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2016.00151","article-title":"Cutaneous leishmaniasis vaccination: a matter of quality","volume":"7","author":"De Luca","year":"2016","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.4049\/jimmunol.180.12.8299","article-title":"The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma","volume":"180","author":"Pakpour","year":"2008","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e14644","DOI":"10.1371\/journal.pone.0014644","article-title":"Potency, efficacy and durability of DNA\/DNA, DNA\/protein and protein\/protein based vaccination using gp63 against Leishmania donovani in BALB\/c mice","volume":"6","author":"Mazumder","year":"2011","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T12:49:35Z","timestamp":1660394975000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2018.00018"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00018","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"article-number":"18"}}